Lb Pharmaceuticals (LBRX) Share-based Compensation (2024 - 2026)
Lb Pharmaceuticals' (LBRX) quarterly Share-based Compensation came in at $10000.0 in Q1 2026, down 98.42% year-on-year from $634000.0 in Q1 2025, and down 99.76% quarter-over-quarter from $4.2 million in Q4 2025.
Lb Pharmaceuticals (LBRX) Share-based Compensation (2024 - 2026) Analysis & Trends
Lb Pharmaceuticals' Share-based Compensation history runs 3 years deep, the most recent figure standing at $10000.0 for Q1 2026.
- On a quarterly basis, Share-based Compensation fell 98.42% year-over-year to $10000.0 in Q1 2026; TTM through Mar 2026 was $10000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $29.1 million, up 40885.92% from the prior year.
- Share-based Compensation eased to $10000.0 in Q1 2026 per LBRX's latest filing, from $4.2 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $4.2 million in Q4 2025 and bottomed at $10000.0 in Q1 2026.
- The 3-year median for Share-based Compensation is $118000.0 (2024), against an average of $1.0 million.
- Across the five-year window, Share-based Compensation dropped 4.24% in 2025 and tumbled 98.42% in 2026, its largest moves.
- Year by year, Share-based Compensation stood at $118000.0 in 2024, then surged by 3451.69% to $4.2 million in 2025, then plunged by 99.76% to $10000.0 in 2026.
- Per Business Quant, the three latest LBRX Share-based Compensation figures stand at $10000.0 (Q1 2026), $4.2 million (Q4 2025), and $113000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | Lb Pharmaceuticals | 977.73 Mn | 977.73 Mn | - | 10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 4.19 Mn |
| Dec 31, 2025 | 4.19 Mn |
| Sep 30, 2025 | 113,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Mar 31, 2025 | 634,000.00 |
| Mar 31, 2025 | 634,000.00 |
| Sep 30, 2024 | 118,000.00 |
| Sep 30, 2024 | 118,000.00 |